PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky

NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a class action alleging channel stuffing medtech securities fraud has been filed on behalf of shareholders who purchased securities between February 28, 2024 and February 25, 2026. Find out if you could qualify to recover your losses.

GlobeNewsWire • 3 hours ago

PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN FRANCISCO, Aug. 24, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts. The lawsuit seeks to represent investors who purchased or otherwise acquired PROCEPT common stock between February 28, 2024 and February 25, 2026.

PRNewsWire • 29 minutes ago

Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 22, 2026

Kaplan Fox & Kilsheimer LLP Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to a Securities Class Action Deadline on September 22, 2026

GlobeNewsWire • 4 hours ago

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of PRCT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

GlobeNewsWire • 2 hours ago

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT), if they purchased the Company's shares between February 28, 2024 and February 25, 2026, inclusive (the "Class Period").

Newsfile Corp • 11 minutes ago

PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT

LOS ANGELES, Aug. 24, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of PRCT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

PRNewsWire • 11 hours ago

PRCT FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PRCT

New York, New York--(Newsfile Corp. - August 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased PROCEPT common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp • Aug 23, 2026

PRCT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PRCT

New York, New York--(Newsfile Corp. - August 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased PROCEPT common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp • Aug 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT

NEW YORK, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

GlobeNewsWire • Aug 21, 2026

PRCT DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

NEW YORK, Aug. 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.

GlobeNewsWire • Aug 21, 2026